Comparative evaluation of 0.2% glyceryl trinitrate vs. 2% diltiazem ointment in treatment of chronic anal fissure treatment - a randomized trial
- 57 Downloads
The initial management of chronic anal fissures nowadays is increasingly becoming medical since surgical procedures may be complicated by prolonged healing of wounds, higher incidence of incontinence of flatus/ mucous, anaesthesia requirement and higher cost. Medical treatment can be carried out on an outpatient basis and is cost-effective.
Aim and study design
We conducted a prospective randomised trial to comparatively evaluate the topical efficacy and complications of 0.2% GTN vs. 2% Diltiazem ointment in patients with chronic anal fissure.
A total of fifty patients were randomly assigned to two groups of 25 patients each, all of whom were treated with topical medication twice daily for a period of six weeks: group A was treated with 0.2% glyceryl trinitrate and group B with 2% diltiazem. None of the patients in either group received analgesics in any form during the course of treatment and follow-up. Cases of acute anal fissure, pregnancy, Crohn’s disease, HIV, tuberculosis, fistula in ano or anal cancer, known allergy to drugs, heart disease, hypertension and patients who refused consent were excluded.
The mean age of patients in both groups (34.6±12.8 vs. 30.6±9.5 years) was comparable. Group A (GTN) comprised 19 males and 6 females and Group B (Diltiazem) 17 males and 8 females (p>.05). The mean duration of symptoms for both groups was 16.64±12.3 vs. 16.08±11.9 weeks, and the mean pain score of patients before treatment was 8.64±0.95 vs. 8.44±1.19 weeks, which was comparable. Perceptible pain relief as compared to pretreatment levels was recorded for both groups after six weeks of therapy (p=.905). Complete healing was observed in 72% patients in group A vs. 80% in group B at the end of six weeks (p value 0.508). Headache was reported in 36% patients in group A and 8% in group B; this difference was statistically significant (p value 0.041). The incidence of recurrence in both groups was comparable at 3-month follow-up (p value 0.756).
Both 0.2% GTN and 2% Diltiazem ointment are equally effective in chronic anal fissure treatment in terms of symptomatic pain relief, healing and recurrence, but headache is a troublesome side effect in patients treated with glyceryl trinitrate ointment. When considering medical management of chronic anal fissure, 2% Diltiazem ointment may be preferable as first-line treatment.
KeywordsChronic anal fissure glyceryl trinitrate diltiazem ointment
Unable to display preview. Download preview PDF.
- 1.Utzig MJ, Krosean AJ, Buhr. Concepts in pathogenesis and treatment of chronic anal fissure–a review of literature. Am j Gastroenterol 2003; 8:968–74Google Scholar
- 8.Lund JN, Parsons SL, Scholefield JH. Spasm of the internal anal sphincterin anal fissure-cause or effect? Gastroenterology 1996; 110:A711Google Scholar
- 11.Jawaid M, Masood J, Salim M. Topical diltiazem hydrochloride and glyceryl trinitrate in the treatment of chronic anal fissure. J Coll Phys Surg Pak 2009; 19:614–9Google Scholar
- 12.Rithin Suvarna, Hanumanthappa MB, Panchami, et al. Topical diltiazem versus topical glyceryl trinitrate (GTN) in the treatment of chronic anal fissure: prospective study. Int J Biol Med Res 2012; 3:1747–50Google Scholar